T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy.

about

T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy.

Item

http://www.wikidata.org/entity/Q50420406

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

T cells specific for a TAP-ind ...... fully exploitable for therapy.

@en

T cells specific for a TAP-ind ...... fully exploitable for therapy.

@nl

type

Item

label

T cells specific for a TAP-ind ...... fully exploitable for therapy.

@en

T cells specific for a TAP-ind ...... fully exploitable for therapy.

@nl

prefLabel

T cells specific for a TAP-ind ...... fully exploitable for therapy.

@en

T cells specific for a TAP-ind ...... fully exploitable for therapy.

@nl

P1476

T cells specific for a TAP-ind ...... fully exploitable for therapy.

@en

P2093

Bianca J Querido

http://www.w3.org/2001/XMLSchema#string

Elien M Doorduijn

http://www.w3.org/2001/XMLSchema#string

Marjolein Sluijter

http://www.w3.org/2001/XMLSchema#string

Sjoerd H van der Burg

http://www.w3.org/2001/XMLSchema#string

P2860

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.

Cross-presentation, dendritic cells, tolerance and immunity.

Antigen bias in T cell cross-priming.

Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.

Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase

P304

e1382793

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1382793

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thorbald van Hall

Koen A Marijt

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29399388

http://www.w3.org/2001/XMLSchema#string

P932

5790395

http://www.w3.org/2001/XMLSchema#string